{
  "ptid_time": "137_S_4672_2012-04-16",
  "img_path": "/data/qiuhui/data/adni/images/137_S_4672/2012-04-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 37,858 mm³, 26.1% above the reference mean. With a Z-score of 0.62 (73.2th percentile), this represents normal volume ; hippocampal volume measures 5,794 mm³, 27.8% below the reference mean. With a Z-score of -2.78 (0.3th percentile), this represents significant atrophy; whole brain volume measures 994,789 mm³, 12.3% below the reference mean. With a Z-score of -1.74 (4.1th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,797 mm³, 34.4% below the reference mean. With a Z-score of -2.38 (0.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,774 mm³, 25.8% below the reference mean. With a Z-score of -2.14 (1.6th percentile), this represents significant atrophy; middle temporal gyrus volume measures 16,802 mm³, 25.0% below the reference mean. With a Z-score of -2.06 (2.0th percentile), this represents significant atrophy. ",
  "text_data": "Age is 66.8 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 21.0. MoCA: 17.0. Logical Memory: 3.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.55 SUVR (profound elevated); Amyloid beta: 447.80 pg/mL (moderate reduced); Total tau: 337.50 pg/mL (mild elevated); Phosphorylated tau: 33.17 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus, middle temporal gyrus) with Z-scores well below -2.0, alongside moderate whole-brain atrophy. Clinically, the patient has low MMSE (21) and MoCA (17) scores, APOE4 homozygosity, and biomarker evidence of amyloid pathology (AV45 profoundly elevated, Aβ moderately reduced) and neurodegeneration (elevated T-tau and P-tau).  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease)  \n**Confidence:** **High** (consistent structural, biomarker, and cognitive deficits)",
  "timestamp": "2025-07-26T16:40:49.032487"
}